All News

Collaboration reinforces value of connecting proprietary and third-party data.

Continued push for latest technology in biopharma will advance collection of patient data.

Updated guidance reflects progress of ongoing dialog between biopharma companies and investors toward achieving more effective ESG communications.

FDA recently approved the disease-modifying therapy for adults with hemolytic anemia caused by PK (pyruvate kinase) deficiency.

Acquisition will extend UBC's services to include an affordability solution.

ESG Evaluation names Sanofi as one of the most sustainability-committed companies.

Three pharma companies represented in top 100.

Obstacles in data exchange remain for industry.

Partnership will utilize Medable's trial software platform to enhance access.

COVID-19 response, global workforce both among highlights.

Monoclonal antibody manufacturing site will help deliver innovative medicines to patients around the world.

Scientific vacancies in the UK are up 58% in 2021 compared to 2020, says report.

Funding brings total investment to $123 million.

Indegene’s 2021–22 survey on the digital habits of HCPs across major regions provides some answers to pharma marketers looking to boost their post-pandemic physician engagement campaigns.

Investigational New Drug application accepted for natural killer cell therapy.

Pharma R&D return on investment rises to highest level since 2014.

Ashfield Engage and ysura announce partnership to transform HCP and pharma interactions through a superior customer experience

In a highly unusual decision for a therapy approved by FDA, CMS has taken action to limit prescribing and use of Biogen’s new and controversial Alzheimer’s treatment Aduhelm.

As big tech’s healthcare disruption efforts flag, biopharma can step up to empower patients and improve care, writes Rohit Gupta.

Indegene’s Kay Uttech won the “Engagement Achievement Award” by the Healthcare Businesswomen’s Association (HBA) for her contribution for promoting gender parity in the industry in 2021. 

Sameer Rabbani talks to Pharm Exec about the new initiative from GSK Consumer Healthcare’s Theraflu to provide relief for those facing access barriers to sick time and raise awareness of the cultural stigma associated with taking a sick day.

PING Innovation Award recognizes individuals and organizations whose ideas, products, services or processes in life sciences sector are making a positive impact on people‘s lives.

Expanded global offerings allow life science companies to make confident, data-driven decisions tailored to their patient populations.

AstraZeneca’s Niko Andre discusses the power of patient partnership in driving medical progress.

Analytic work will drive regulatory grade RWD studies and therapeutic evidence to improve patient outcomes.

Novo Nordisk announces plans to invest more than 17bn Danish kroner constructing three new manufacturing facilities in Kalundborg, Denmark.​

Pharma executives cite supply chain visibility as critical solution to alleviating product loss and security concerns, while one-third are dissatisfied with current solutions.

Workplace equality accelerating for healthcare industry’s Gender Parity Collaborative.